Halper Sadeh LLC Urges Amylyx Pharmaceuticals Shareholders to Act

Halper Sadeh LLC, a law firm specializing in investor rights, is reaching out to shareholders of Amylyx Pharmaceuticals, Inc. regarding potential breaches of fiduciary duty by the company’s officers and directors. Shareholders are encouraged to contact the firm promptly, as time may be limited to enforce their rights.

On November 28, 2025, the firm announced its investigation into whether the leadership of Amylyx Pharmaceuticals has acted in the best interests of its shareholders. Those who own shares in the company and have held them long-term may be eligible to pursue corporate governance reforms or seek recovery of funds through legal action.

The investigation aims to determine if shareholders can obtain relief and benefits, which could include a court-approved financial incentive award. Interested shareholders can learn more about their legal rights and options by reaching out to Daniel Sadeh or Zachary Halper at the firm.

Halper Sadeh LLC operates on a contingent fee basis, meaning shareholders will not incur any out-of-pocket expenses for legal fees or costs. This arrangement allows shareholders to engage in legal action without worrying about immediate financial burdens.

Importance of Shareholder Participation

The firm emphasizes the significance of shareholder involvement in fostering a more transparent and accountable corporate environment. Engaging in this process not only aids in implementing necessary reforms but also enhances the overall management of the organization, ultimately benefiting all shareholders.

Halper Sadeh LLC has built a reputation for representing investors globally who have been affected by securities fraud and corporate misconduct. The firm’s attorneys have successfully recovered millions of dollars for defrauded investors and have played a crucial role in enacting corporate reforms.

For those interested in pursuing potential claims against Amylyx Pharmaceuticals, the firm encourages immediate contact. Shareholders can reach Halper Sadeh LLC at (212) 763-0060 or via email at [email protected] or [email protected].

The firm’s office is located at One World Trade Center, 85th Floor, New York, NY 10007. As noted in their communication, prior results do not guarantee a similar outcome for current cases.

The call to action from Halper Sadeh LLC underscores the critical role that informed and active shareholders play in corporate governance and accountability. By standing together, investors can effect meaningful change within companies like Amylyx Pharmaceuticals.